Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
NYR-BI03
Myocardial Ischemia and Arrhythmia Control
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
News & Insights
Home
>
News & Insights
>
Media
Presentations & Interviews
Media
Newsletters
Publications
Media
Filter by Year:
2025
2024
2021
2020
2-May-2025
Nyrada Inc (ASX:NYR) Advances Phase I Clinical Trial to Third Cohort
7-Apr-2025
Nyrada's Neuroprotective Drug Advances With Key Partnerships
31-Mar-2025
Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug
21-Mar-2025
These ASX companies are stepping up to tackle traumatic brain injury head-on
1
